Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215130834> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3215130834 abstract "<b>Background:</b> Selective inhibition of Receptor interacting serine/threonine protein kinase 1 (RIPK1) could alleviate the hyperinflammatory syndrome occurring in patients with severe coronavirus 2019 (COVID-19). <b>Aim:</b> To explore safety, immunomodulatory and clinical effects of RIPK1 inhibitor, SAR443122 in patients with severe COVID-19. <b>Methods:</b> Patients were randomised (2:1) to receive SAR443122 600mg (300mg twice daily; treatment) or placebo up to 14 days (D; NCT04469621). Safety was assessed up to 28D. The primary outcome was relative change from baseline in C-reactive protein (CRP) level on D7. The time to clinical improvement using 7-point ordinal scale, ventilator/respiratory failure free days (VFD/RFFD), change in SpO<sub>2</sub>/FiO<sub>2</sub> ratio, biomarkers (LDH, IL-6, IL-8) were also explored. <b>Results:</b> The treatment difference in relative change from baseline in CRP is shown in Table. Median time to 50% decrease in CRP level from baseline was 3 vs 5D (p=0.056) in treatment vs placebo groups. Median time for ≥2-point improvement in 7-point scale was 8 vs 10D in treatment vs placebo (p=0.38). Consistent trends towards greater improvements were observed in treatment vs placebo in mean VFD/RFFD, change in SpO<sub>2</sub>/FiO<sub>2</sub> ratio and biomarkers (Table). SAR443122 was considered safe and well tolerated. <b>Conclusion:</b> These preliminary results indicate the need for a larger confirmatory trial to further assess clinically significant effects." @default.
- W3215130834 created "2021-12-06" @default.
- W3215130834 creator A5003155363 @default.
- W3215130834 creator A5005424988 @default.
- W3215130834 creator A5010306886 @default.
- W3215130834 creator A5018154365 @default.
- W3215130834 creator A5024952302 @default.
- W3215130834 creator A5035874341 @default.
- W3215130834 creator A5073488167 @default.
- W3215130834 creator A5074097531 @default.
- W3215130834 creator A5074437646 @default.
- W3215130834 creator A5084577743 @default.
- W3215130834 creator A5087292154 @default.
- W3215130834 creator A5091200779 @default.
- W3215130834 date "2021-09-05" @default.
- W3215130834 modified "2023-10-14" @default.
- W3215130834 title "Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19" @default.
- W3215130834 doi "https://doi.org/10.1183/13993003.congress-2021.pa2363" @default.
- W3215130834 hasPublicationYear "2021" @default.
- W3215130834 type Work @default.
- W3215130834 sameAs 3215130834 @default.
- W3215130834 citedByCount "2" @default.
- W3215130834 countsByYear W32151308342022 @default.
- W3215130834 countsByYear W32151308342023 @default.
- W3215130834 crossrefType "proceedings-article" @default.
- W3215130834 hasAuthorship W3215130834A5003155363 @default.
- W3215130834 hasAuthorship W3215130834A5005424988 @default.
- W3215130834 hasAuthorship W3215130834A5010306886 @default.
- W3215130834 hasAuthorship W3215130834A5018154365 @default.
- W3215130834 hasAuthorship W3215130834A5024952302 @default.
- W3215130834 hasAuthorship W3215130834A5035874341 @default.
- W3215130834 hasAuthorship W3215130834A5073488167 @default.
- W3215130834 hasAuthorship W3215130834A5074097531 @default.
- W3215130834 hasAuthorship W3215130834A5074437646 @default.
- W3215130834 hasAuthorship W3215130834A5084577743 @default.
- W3215130834 hasAuthorship W3215130834A5087292154 @default.
- W3215130834 hasAuthorship W3215130834A5091200779 @default.
- W3215130834 hasConcept C126322002 @default.
- W3215130834 hasConcept C142724271 @default.
- W3215130834 hasConcept C203092338 @default.
- W3215130834 hasConcept C204787440 @default.
- W3215130834 hasConcept C27081682 @default.
- W3215130834 hasConcept C535046627 @default.
- W3215130834 hasConcept C71924100 @default.
- W3215130834 hasConcept C90924648 @default.
- W3215130834 hasConceptScore W3215130834C126322002 @default.
- W3215130834 hasConceptScore W3215130834C142724271 @default.
- W3215130834 hasConceptScore W3215130834C203092338 @default.
- W3215130834 hasConceptScore W3215130834C204787440 @default.
- W3215130834 hasConceptScore W3215130834C27081682 @default.
- W3215130834 hasConceptScore W3215130834C535046627 @default.
- W3215130834 hasConceptScore W3215130834C71924100 @default.
- W3215130834 hasConceptScore W3215130834C90924648 @default.
- W3215130834 hasLocation W32151308341 @default.
- W3215130834 hasOpenAccess W3215130834 @default.
- W3215130834 hasPrimaryLocation W32151308341 @default.
- W3215130834 hasRelatedWork W195854409 @default.
- W3215130834 hasRelatedWork W2009588589 @default.
- W3215130834 hasRelatedWork W2080033839 @default.
- W3215130834 hasRelatedWork W2329290186 @default.
- W3215130834 hasRelatedWork W2970916347 @default.
- W3215130834 hasRelatedWork W3015996685 @default.
- W3215130834 hasRelatedWork W3200621203 @default.
- W3215130834 hasRelatedWork W4230120862 @default.
- W3215130834 hasRelatedWork W4233016836 @default.
- W3215130834 hasRelatedWork W4285099082 @default.
- W3215130834 isParatext "false" @default.
- W3215130834 isRetracted "false" @default.
- W3215130834 magId "3215130834" @default.
- W3215130834 workType "article" @default.